Gluomni M1: Complete Guide to Metformin SR and Glimepiride

Gluomni M1 is a prescription medicine in the Diabetes Care range of EMK Omni Pharma, based in Mysuru, Karnataka. Each uncoated bilayer tablet contains Metformin Hydrochloride IP 500 mg in a sustained release form and Glimepiride IP 1 mg, along with approved excipients. The generic name printed on the pack is Metformin Hydrochloride (SR) and Glimepiride Tablets IP.

EMK Omni Pharma markets Gluomni M1. The tablets are produced for the company at GMP certified contract manufacturing units and supplied to chemists, clinics and hospitals across India.

The bilayer design keeps the two active ingredients in separate layers of one tablet. One layer releases Metformin slowly across several hours, while the other carries the Glimepiride. That is the reason the tablet has to go down whole.

The Schedule G caution on the carton states that it is dangerous to take this preparation except under medical supervision. That is a legal requirement in India and also sound practical advice, because a medicine that lowers blood glucose has to be matched to your reports.

Metformin belongs to the biguanide class. It acts mainly in the liver, reducing the amount of glucose the liver releases into the blood, and it helps muscle and fat tissue respond better to the insulin the body already makes. Metformin does not push the pancreas to produce extra insulin, so used on its own it rarely drives sugar too low. The sustained release layer spreads delivery across the day, which many people find gentler on the stomach.

Glimepiride belongs to the sulfonylurea class. It acts on the beta cells of the pancreas and encourages them to release more insulin. Because it adds insulin to the system, it can bring readings down quickly, and low blood sugar becomes a real possibility if a meal is skipped.

Combining the two addresses type 2 diabetes from two directions at once: less glucose leaving the liver and more insulin available to move glucose into cells. Whether that pairing suits you is a decision only your doctor can make.

Doctors generally consider a Metformin and Glimepiride combination for adults with type 2 diabetes whose glucose readings have not settled on Metformin with diet and exercise alone. The 1 mg Glimepiride content is the lower of the commonly used strengths, so this version is often chosen when a doctor wants to add a sulfonylurea gently, or when the patient is older, eats at irregular hours, or has had low sugar episodes in the past.

Gluomni M1 is not used for type 1 diabetes and it is not a treatment for diabetic ketoacidosis. It is also not a weight reduction product or a general tonic. Only a registered medical practitioner can judge whether this combination and this strength suit you, after reviewing fasting sugar, post meal sugar, HbA1c, kidney function and the other medicines you take.

Tablets are one part of type 2 diabetes management, not the whole of it. A plan built by an Indian physician usually includes a balanced meal pattern with controlled portions of rice and roti, daily physical activity, weight management, blood pressure and cholesterol checks, eye and foot screening, and periodic HbA1c testing.

Gluomni M1 supports the medicine part of that plan. It may help bring readings closer to the target your doctor sets, and results are usually better when tablets and lifestyle changes pull in the same direction. Type 2 diabetes is a long term condition, so treatment is reviewed and adjusted over the years rather than completed.

This hub sits alongside ten focused articles:

Speak to your doctor before starting Gluomni M1 if you have kidney or liver problems, heart failure, a history of low blood sugar, or if you are pregnant, planning a pregnancy or breastfeeding. Mention every other medicine you take, including Ayurvedic preparations and anything bought over the counter.

Once treatment has started, contact your doctor if you get repeated shakiness, sweating, confusion or sudden hunger between meals, if you have persistent vomiting or breathing difficulty, or if a scan with contrast dye or a surgery is planned. Never change the dose, stop the tablet or add another diabetes medicine on your own.

This article is for general information only and is not a substitute for advice from a registered medical practitioner.